It is among the top trials being conducted, in order, to date in North America.
Dias.
placebo in patients with cardiovascular diseases will be conducted in the future—though I am most optimistic that our existing studies will provide definitive answers.” Patients with coronary artery disease already have a small risk of developing cardiovascular disease that substantially increases their probability of dying within 30 years of diagnosis.
Additional results from a phase 3 clinical trial will be presented at the meeting.